http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2260774-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1997-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28ec19d5be3d05dd0bc9e4763775342f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_743b7fdf573b4d226127adcf6adb87cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f7c2f7cc8bf7d236379ccf50dcc6e2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_462f6608a62b314f2cccebedf14c77c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50ff75cd1fa16d89274e3e0c899f289c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72c885c0de0da3dfd0a9453ec0f34295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_761f3f10f5b31b9ca40bca0a997fbcbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2562bec2962790e5ee2968f0e909757a
publicationDate 1998-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2260774-A1
titleOfInvention Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
abstract A class of substituted or 7,8-ring fused 1,2,4triazolo[4,3-b]pyridazine derivatives, possessing an optionally substituted cycloalkyl, phenyl or heteroaryl substituent at the 3-position and a substituted alkoxy moiety at the 6-position, are selective ligands for GABA A receptors, in particular having high affinity for the a2 and/or 0 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of disorders of the central nervous system, including anxiety and convulsions.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113009014-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113009014-B
priorityDate 1996-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414364179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID577392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 29.